Image used for representational purpose only. 
Bengaluru

Treating AMD: Firm completes animal trials

Dry Age-related Macular Degeneration (AMD) may be a thing of the past, with Bengaluru-based cell therapy firm, Eyestem, successfully completing animal trials.

Express News Service

BENGALURU: Dry Age-related Macular Degeneration (AMD) may be a thing of the past, with Bengaluru-based cell therapy firm, Eyestem, successfully completing animal trials.

The firm has been working towards finding a treatment for the incurable eye disease that has plagued nearly 40 million people in the country, and 170 million others worldwide. Eyestem has successfully completed animal testing for its flagship cell therapy treatment, ‘EyecyteRPE’.

“These results will allow us to move forward with final manufacturing, followed by toxicity studies and start human studies in the last quarter of 2022,” Dr Rajarshi Pal, co-founder and chief scientist at Eyestem.

Indian national sentenced to 19 years in US prison over foiled assassination plot against seperatist Pannun

MEA says Indus Waters Treaty stance unchanged as Pakistan minister attends SCO forum in Delhi

Congress says Rajasthan panchayat results expose BJP's 'misrule'; BJP vows to review losses

Shinde’s Sena joins hands with Congress, Ajit Pawar’s NCP to keep BJP out of power in Cooperative Bank elections

Trade diplomacy can't replace industrial might